Announcements

The Reagan-Udall Foundation for the FDA (the Foundation) seeks nominations for its annual Innovations in Regulatory Science & Policy Awards.
(October 11, 2024) Steven A. Grossman, JD; Jeff Shuren, MD, JD; and the Real-World Evidence Collaborative will receive the Reagan-Udall Foundation for the FDA’s 2024 Innovations in Regulatory Science Awards on December 10. The prestigious awards…
(WASHINGTON, July 26, 2024) – The Reagan-Udall Foundation for the FDA (the Foundation) launched a new tool for leaders in health care delivery—the RAISE Action Framework.

Coverage

TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying the clinical research process, today announced its participation in numerous sessions at the…
In fact, according to a report by the independent Reagan-Udall Foundation, the CTP under the previous administration suffered from ineffective leadership, a lack of direction and a culture that stifles scientific integrity.
In 2024, a workshop cohosted by FDA and the Reagan-Udall Foundation for the FDA (Reagan-Udall) focusing on advancing psychedelic clinical study design. Also in 2024, a second workshop by Reagan-Udall focusing specifically on understanding potential…